Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility, Safety, and Preliminary Efficacy of Combined Intracalvariosseous and Intravenous Antibiotic Infusion for Moderate to Severe Bacterial Meningitis

NCT07826351 is registered in ClinicalTrials.gov with yilong Wang as lead sponsor.

NCT NCT07826351
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07826351 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility, Safety, and Preliminary Efficacy of Combined Intracalvariosseous and Intravenous Antibiotic Infusion for Moderate to Severe Bacterial Meningitis
Lead sponsor
yilong Wang
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 21, 2026
Completion date
March 31, 2027
Enrollment
9 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial meningitis, blood-brain barrier